China National Medicines Corporation Ltd. (600511.SS)
CNY 28.99
(0.1%)
CNY 28.99
(0.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 14.87 Billion CNY | 8.18% |
| 2022 | 13.74 Billion CNY | 4.8% |
| 2021 | 13.11 Billion CNY | 11.08% |
| 2020 | 11.81 Billion CNY | -1.86% |
| 2019 | 12.03 Billion CNY | 10.41% |
| 2018 | 10.9 Billion CNY | 1.78% |
| 2017 | 10.7 Billion CNY | 216.41% |
| 2016 | 3.38 Billion CNY | 11.27% |
| 2015 | 3.04 Billion CNY | 2.86% |
| 2014 | 2.95 Billion CNY | 2.55% |
| 2013 | 2.88 Billion CNY | 7.2% |
| 2012 | 2.68 Billion CNY | 33.24% |
| 2011 | 2.01 Billion CNY | -1.5% |
| 2010 | 2.04 Billion CNY | 21.01% |
| 2009 | 1.69 Billion CNY | 50.07% |
| 2008 | 1.12 Billion CNY | -8.24% |
| 2007 | 1.23 Billion CNY | 59.53% |
| 2006 | 771.05 Million CNY | 1.55% |
| 2005 | 759.27 Million CNY | 7.78% |
| 2004 | 704.48 Million CNY | 13.66% |
| 2003 | 619.79 Million CNY | 51.63% |
| 2002 | 408.75 Million CNY | 35.8% |
| 2001 | 300.98 Million CNY | 16.51% |
| 2000 | 258.32 Million CNY | -42.44% |
| 1999 | 448.79 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 15.87 Billion CNY | 1.71% |
| 2024 Q1 | 14.89 Billion CNY | 0.16% |
| 2024 Q2 | 15.61 Billion CNY | 4.79% |
| 2023 Q1 | 13.65 Billion CNY | -0.66% |
| 2023 Q3 | 14.82 Billion CNY | 2.2% |
| 2023 Q4 | 14.87 Billion CNY | 0.31% |
| 2023 FY | 14.87 Billion CNY | 8.18% |
| 2023 Q2 | 14.5 Billion CNY | 6.22% |
| 2022 Q2 | 12.32 Billion CNY | -2.45% |
| 2022 FY | 13.74 Billion CNY | 4.8% |
| 2022 Q4 | 13.74 Billion CNY | -1.82% |
| 2022 Q3 | 14 Billion CNY | 13.61% |
| 2022 Q1 | 12.63 Billion CNY | -3.68% |
| 2021 Q2 | 13.1 Billion CNY | 15.47% |
| 2021 Q4 | 13.11 Billion CNY | -4.03% |
| 2021 FY | 13.11 Billion CNY | 11.08% |
| 2021 Q3 | 13.67 Billion CNY | 4.3% |
| 2021 Q1 | 11.35 Billion CNY | -3.89% |
| 2020 Q4 | 11.81 Billion CNY | -2.13% |
| 2020 FY | 11.81 Billion CNY | -1.86% |
| 2020 Q1 | 11.28 Billion CNY | -6.2% |
| 2020 Q2 | 11.15 Billion CNY | -1.17% |
| 2020 Q3 | 12.06 Billion CNY | 8.17% |
| 2019 FY | 12.03 Billion CNY | 10.41% |
| 2019 Q1 | 10.02 Billion CNY | -8.04% |
| 2019 Q2 | 10.9 Billion CNY | 8.78% |
| 2019 Q4 | 12.03 Billion CNY | -5.76% |
| 2019 Q3 | 12.77 Billion CNY | 17.12% |
| 2018 Q3 | 10.73 Billion CNY | 0.84% |
| 2018 FY | 10.9 Billion CNY | 1.78% |
| 2018 Q1 | 10.86 Billion CNY | 1.43% |
| 2018 Q2 | 10.64 Billion CNY | -1.99% |
| 2018 Q4 | 10.9 Billion CNY | 1.52% |
| 2017 Q2 | 9.52 Billion CNY | 189.2% |
| 2017 FY | 10.7 Billion CNY | 216.41% |
| 2017 Q1 | 3.29 Billion CNY | -2.67% |
| 2017 Q4 | 10.7 Billion CNY | 4.92% |
| 2017 Q3 | 10.2 Billion CNY | 7.13% |
| 2016 Q1 | 2.78 Billion CNY | -8.39% |
| 2016 Q2 | 2.86 Billion CNY | 2.68% |
| 2016 Q3 | 3.08 Billion CNY | 7.84% |
| 2016 FY | 3.38 Billion CNY | 11.27% |
| 2016 Q4 | 3.38 Billion CNY | 9.69% |
| 2015 Q2 | 2.83 Billion CNY | -0.22% |
| 2015 Q1 | 2.84 Billion CNY | -3.85% |
| 2015 FY | 3.04 Billion CNY | 2.86% |
| 2015 Q4 | 3.04 Billion CNY | 2.2% |
| 2015 Q3 | 2.97 Billion CNY | 4.91% |
| 2014 Q4 | 2.95 Billion CNY | -8.75% |
| 2014 Q1 | 2.75 Billion CNY | -4.43% |
| 2014 Q2 | 2.77 Billion CNY | 0.88% |
| 2014 Q3 | 3.24 Billion CNY | 16.57% |
| 2014 FY | 2.95 Billion CNY | 2.55% |
| 2013 Q4 | 2.88 Billion CNY | 0.08% |
| 2013 FY | 2.88 Billion CNY | 7.2% |
| 2013 Q1 | 2.37 Billion CNY | -11.71% |
| 2013 Q2 | 2.56 Billion CNY | 8.09% |
| 2013 Q3 | 2.88 Billion CNY | 12.24% |
| 2012 FY | 2.68 Billion CNY | 33.24% |
| 2012 Q1 | 2.15 Billion CNY | 6.54% |
| 2012 Q3 | 2.46 Billion CNY | 4.21% |
| 2012 Q2 | 2.36 Billion CNY | 9.95% |
| 2012 Q4 | 2.68 Billion CNY | 9.15% |
| 2011 FY | 2.01 Billion CNY | -1.5% |
| 2011 Q4 | 2.01 Billion CNY | 10.21% |
| 2011 Q3 | 1.83 Billion CNY | -12.88% |
| 2011 Q1 | 1.86 Billion CNY | -8.94% |
| 2011 Q2 | 2.1 Billion CNY | 12.66% |
| 2010 Q4 | 2.04 Billion CNY | 7.03% |
| 2010 Q2 | 1.77 Billion CNY | -1.07% |
| 2010 Q1 | 1.79 Billion CNY | 5.97% |
| 2010 FY | 2.04 Billion CNY | 21.01% |
| 2010 Q3 | 1.91 Billion CNY | 7.86% |
| 2009 FY | 1.69 Billion CNY | 50.07% |
| 2009 Q4 | 1.69 Billion CNY | 21.63% |
| 2009 Q3 | 1.39 Billion CNY | 14.85% |
| 2009 Q2 | 1.21 Billion CNY | 5.83% |
| 2009 Q1 | 1.14 Billion CNY | 1.51% |
| 2008 Q3 | 1.23 Billion CNY | -1.5% |
| 2008 FY | 1.12 Billion CNY | -8.24% |
| 2008 Q4 | 1.12 Billion CNY | -8.34% |
| 2008 Q1 | 1.1 Billion CNY | -10.08% |
| 2008 Q2 | 1.25 Billion CNY | 13.03% |
| 2007 Q4 | 1.23 Billion CNY | 9.0% |
| 2007 FY | 1.23 Billion CNY | 59.53% |
| 2007 Q3 | 1.12 Billion CNY | 13.91% |
| 2007 Q1 | 916.23 Million CNY | 18.83% |
| 2007 Q2 | 990.62 Million CNY | 8.12% |
| 2006 Q2 | 712.44 Million CNY | -0.87% |
| 2006 Q4 | 771.05 Million CNY | -1.58% |
| 2006 Q3 | 783.39 Million CNY | 9.96% |
| 2006 FY | 771.05 Million CNY | 1.55% |
| 2006 Q1 | 718.68 Million CNY | -5.35% |
| 2005 FY | 759.27 Million CNY | 7.78% |
| 2005 Q4 | 759.27 Million CNY | -0.46% |
| 2005 Q1 | 644.48 Million CNY | -8.52% |
| 2005 Q2 | 662.19 Million CNY | 2.75% |
| 2005 Q3 | 762.81 Million CNY | 15.19% |
| 2004 Q2 | 519.61 Million CNY | -6.65% |
| 2004 Q4 | 704.48 Million CNY | 25.81% |
| 2004 Q3 | 559.93 Million CNY | 7.76% |
| 2004 Q1 | 556.61 Million CNY | -10.19% |
| 2004 FY | 704.48 Million CNY | 13.66% |
| 2003 Q1 | 408.18 Million CNY | -0.14% |
| 2003 FY | 619.79 Million CNY | 51.63% |
| 2003 Q2 | 517.58 Million CNY | 26.8% |
| 2003 Q3 | 529.03 Million CNY | 2.21% |
| 2003 Q4 | 619.79 Million CNY | 17.16% |
| 2002 Q2 | 320.83 Million CNY | 0.0% |
| 2002 FY | 408.75 Million CNY | 35.8% |
| 2002 Q4 | 408.75 Million CNY | 0.0% |
| 2001 FY | 300.98 Million CNY | 16.51% |
| 2000 FY | 258.32 Million CNY | -42.44% |
| 1999 FY | 448.79 Million CNY | 0.0% |